Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2025.Mar.20

Announcement on behalf of OBIGEN that it has achieved the objectives of interim analysis for Phase 2 clinical trial of OBI-858

2025.Mar.18

Announcement on behalf of OBIGEN that BOD resolved to apply for public offering and listing in the TPEx Emerging Stock Board

2025.Mar.18

Announcement on behalf of OBIGEN that BOD resolved to complete replacement of non-physical stocks

2025.Mar.18

Announcement on behalf of OBIGEN that the BOD resolved to convene the 2025 Annual General Shareholders' Meeting

2025.Mar.18

Announcement on behalf of OBIGEN of not Distributing Dividends of 2024

2025.Mar.18

Announcement on behalf of OBIGEN of the BOD’s resolution to lift the non-competition restrictions for CEO

2025.Mar.18

Announcement on behalf of OBIGEN that BOD nominated Dr. Heidi Wang as the Chairperson

2025.Mar.10

Announcement on behalf of OBIGEN the change of its financial and accounting officer

2025.Mar.10

Announcement on behalf of OBIGEN the resignation of Chief Commercial Officer

2025.Mar.10

Announcement of not Distributing Dividends in 2024

News

Latest News

Events

Latest events